Kestra Investment Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$302K Sell
1,369
-660
-33% -$183K 0.01% 418
2026
Q1
$599K Sell
2,029
-1,731
-46% -$514K 0.01% 270
2025
Q4
$1.03M Sell
3,760
-671
-15% -$182K 0.03% 200
2025
Q3
$1.2M Buy
4,431
+951
+27% +$259K 0.03% 179
2025
Q2
$959K Sell
3,480
-3,365
-49% -$915K 0.03% 197
2025
Q1
$1.82M Buy
6,845
+6,625
+3,011% +$1.63M 0.06% 107
2024
Q4
$51.1K Buy
+220
New +$50.6K ﹤0.01% 528

Other funds holding CME

Kestra Investment Management's CME Position: Q2 2026 in Review

Kestra Investment Management reduced its CME Group (CME) stake by 33% in Q2 2026, selling an estimated $183K and leaving 1,369 shares worth $302K. The position accounts for 0.01% of the portfolio, ranked #418.

Kestra Investment Management first reported a position in CME in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.82M in Q1 2025. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Kestra Investment Management held 1,369 shares of CME Group worth $302K as of Q2 2026.
  • Kestra Investment Management sold 660 CME Group shares in Q2 2026, an estimated $183K.
  • CME Group made up 0.01% of Kestra Investment Management's portfolio in Q2 2026, its #418 holding.
  • Kestra Investment Management first reported a position in CME Group in Q4 2024 and has held it in 7 quarters since.
  • Kestra Investment Management's CME Group position peaked at $1.82M in Q1 2025.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Kestra Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.